HighPeak Energy, Inc. Reveals Change in CEO Leadership

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Sep 16 2025

0mins

HPK+6.21%

FANG+1.3%

Should l Buy HPK?

Source: Newsfilter

Leadership Change: Jack Hightower has announced his retirement as CEO and Chairman of HighPeak Energy, with Michael L. Hollis appointed as Interim CEO, effective immediately.
Management Transition: Hightower will also retire from managing the Highpeak Funds, which own approximately 64.4% of the company's shares, with a new management committee taking over.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy HPK?" and start using high-conviction signals backed by rigorous historical data.

HPK

$4.79+Infinity%1D

Analyst Views on HPK

Wall Street analysts forecast HPK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HPK is 9.50 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Analyst Rating

1 Buy

0 Hold

1 Sell

Hold

Current: 4.510

Low

7.00

Averages

9.50

High

12.00

Current: 4.510

Low

7.00

Averages

9.50

High

12.00

BofA

Underperform

downgrade

2026-01-16

Reason

BofA

Price Target

AI Analysis

2026-01-16

downgrade

Underperform

Reason

BofA lowered the firm's price target on HighPeak Energy to $5 from $6.50 and keeps an Underperform rating on the shares. For 2026, the firm remains cautious on the oil backdrop and continues to favor companies with resilient portfolios and low breakevens that fully cover capex and dividends in this environment, the analyst tells investors.

B of A Securities

Noah Hungness

Sell

Initiates

$10

2025-04-07

Reason

B of A Securities

Noah Hungness

Price Target

$10

2025-04-07

Initiates

Sell

Reason

About HPK

HighPeak Energy, Inc. is an independent crude oil and natural gas company. The Company is focused on the acquisition, development, exploration and exploitation of unconventional crude oil and natural gas reserves in the Midland Basin in West Texas. It focuses on the Midland Basin and specifically the Howard and Borden Counties area of the Midland Basin. The Company’s assets include certain rights, title and interests in crude oil and natural gas assets located primarily in Howard and Borden Counties, Texas, and to a lesser extent, Scurry and Mitchell Counties, Texas. The Company’s assets are located in the northeastern part of the Midland Basin. The Midland Basin is part of the Permian Basin of West Texas and Eastern New Mexico. The Permian Basin covers an area of about 96,000 square miles and comprises five sub-regions, including the Midland Basin, the Central Basin Platform, the Delaware Basin, the Northwest Shelf and the Eastern Shelf.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%

Jan 14 2026Benzinga

Strong Financial Performance: TG Therapeutics reported preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million, indicating robust market performance that is expected to boost shareholder confidence.
Significant Stock Surge: Following the earnings report, TG Therapeutics shares jumped 11.6% to $31.10 on Wednesday, reflecting investor optimism about the company's growth potential, which may attract more capital inflow.
Positive Market Reaction: Despite a broader market decline with the Nasdaq Composite falling over 200 points, TG Therapeutics' strong financial data allowed it to stand out among numerous stocks, showcasing its competitiveness in the biopharmaceutical sector.
Optimistic Future Outlook: Although the financial figures are unaudited, the preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.

Mid-to-Low Cap Energy Stocks Face Weak EPS Revisions

Jan 13 2026seekingalpha

Pessimistic Earnings Outlook: Mid-to-low cap energy stocks like Advantage Energy and Forum Energy Technologies have received an 'F' grade for EPS revisions, indicating significant downward adjustments by analysts, reflecting a lack of market confidence in these companies.
Wide Industry Distribution: These stocks span various subsectors including oil and gas exploration, equipment services, storage and transportation, and refining and marketing, suggesting that the entire energy sector is facing widespread challenges in the current economic environment, which may impact overall investor confidence.
Consistent Analyst Ratings: All listed companies have been rated at the lowest level, demonstrating analysts' general concerns about their future profitability, which could lead to increased risk aversion among investors and negatively affect market performance.
Potential Market Reaction: As the earnings season kicks off, investors may remain cautious regarding these stocks, especially against the backdrop of widespread EPS downgrades by analysts, potentially leading to further pressure on their stock prices.

Oil Stocks Losing Appeal: Analysts Downgrade CNQ and SU

Jan 12 2026seekingalpha

Market Uncertainty: Analysts highlight that Canadian heavy oil miners like Canadian Natural Resources (CNQ) and Suncor Energy (SU) saw significant stock declines following Maduro's overthrow, reflecting market concerns about their future, particularly amid a crash in Western Canadian Select (WCS) prices.
Increased Competition Risk: With Venezuelan crude potentially returning, CNQ and SU, which send about a third of their daily output to U.S. Gulf Coast refineries, may face direct competition, further impacting their market share and profitability.
Small Company Risks: Analyst Long Player warns that current economic uncertainty could lead to longer recovery times for smaller oil and gas companies like HighPeak Energy (HPK) and Prairie Operating (PROP), especially with weakening commodity prices, prompting investors to be cautious with stocks under $1 billion market cap.
Investment Strategy Shift: Given the political uncertainty and unclear economic outlook, analysts recommend avoiding investments in small-cap oil and gas stocks, particularly those without income like New Era Energy & Digital (NUAI), to mitigate investment risks.

HighPeak Energy, Inc. Sets Dates for 2025 Third Quarter Earnings Release and Conference Call

Oct 20 2025Newsfilter

Earnings Release Announcement: HighPeak Energy, Inc. plans to release its 2025 third quarter financial and operating results on November 5, 2025, after market close.
Conference Call Details: A conference call and webcast to discuss the results will be held on November 6, 2025, at 11:00 a.m. Central Time, with access available through their website and registration options provided.

VB's Holdings May Offer 16% Profit Potential

Oct 17 2025NASDAQ.COM

Vanguard Small-Cap ETF Analysis: The Vanguard Small-Cap ETF (VB) has an implied analyst target price of $292.99 per unit, indicating a potential upside of 15.71% from its recent trading price of $253.21.
Notable Holdings with Upside Potential: Key underlying holdings such as HighPeak Energy Inc, ASGN Inc, and Enerpac Tool Group Corp show significant upside potential, with target prices exceeding their current trading prices by 37.88%, 20.89%, and 19.55%, respectively.